Skip to content

Neurological Impairment in a Young Population Exposed to Recreational Nitrous Oxide

A Retrospective Study of Neurological Impairment in a Young Population Exposed to Recreational Nitrous Oxide

Status
Terminated
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05469321
Acronym
N2O
Enrollment
20
Registered
2022-07-21
Start date
2022-08-22
Completion date
2025-05-03
Last updated
2026-06-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neuropathy

Brief summary

Nitrous oxide (N2O) is a colorless, flammable, analgesic gas used in surgery and dentistry. The consumption of N2O has increased among young French people aiming to relax because of its short-lived neuropsychological effect (euphoria, depersonalization, analgesia) and its wide availability on the market. It can be responsible in case of prolonged use and overdose of a vitamin B12 deficiency with possible neuropsychiatric complications: sensitivomotor neuropathy, myelopathy, behavioral and cognitive disorders of acute or sub-acute installation. N2O inhibits the activitý of methionine synthase, decreases the activitý of methylmalonyl-CoA mutase leading to vitamin B12 deficiency but in addition to the interference with vitamin B12 metabolism there seems to be a direct toxicity of N20. Myelin alteration was the typical electromyography finding but new axonal profiles were also described. Since myelopathy affects both the posterior and lateral cords, combined spinal cord sclerosis is the most common location of injury associated with N2O intoxication.

Interventions

None, pure observational study following the usual management of the patients

Sponsors

Centre Hospitalier Universitaire de Nīmes
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
15 Years to No maximum
Healthy volunteers
No

Inclusion criteria

patients presenting to the CHU of Nîmes with an acute or sub-acute neurological picture after having consumed N2O \-

Design outcomes

Primary

MeasureTime frameDescription
MRC scorebaselineMRCss - Medical Research Council sum score : This score assigns a rating to each muscle group: "0" = absence of visible contraction visible contractions, " 1 " = visible contractions without movement of limbs, " 2 " = insufficient 2" = insufficient movements to overcome weightlessness, "3" = movements to overcome weightlessness, "4" = movements against weightlessness and resistance, "5" = normal muscle strength.
Romberg scoreBaselineA positive Romberg test means the presence of sensory ataxia
INCAT Sensory Sum score (ISS)Baselinegrades from 0 (no involvement) to 20 (severe involvement)
ONLS - Overall Neuropathy Limitations ScaleBaselineOverall Neuropathy Limitation Scale = arm scale (range 0 to 5) + leg scale (range 0 to 7); (range: 0 (no disability) to 12 (maximum disability)
Rankin scoreBaselinedisability measurement score from 0 (none) to 6 (death)
vitamin B12 levelbaselinevitamin B12 level in µmom/L
methyl malonic acid levelbaselinemethyl-malonic acid level
electroneuromyogrambaselineNormal Yes/No
Cerebral MRIbaselinelesions yes/No
Pan-medullary MRIbaselinelesions yes/No

Countries

France

Contacts

STUDY_DIRECTORAnissa MEGZARI

Centre Hospitalier Universitaire de Nīmes

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 18, 2026